Sicherheit & Nebenwirkungen
Studienlage · Detail Meta-Analyse · Sicherheit & Nebenwirkungen · 2026

A systematic review and meta-analysis of self-reported exposure to cannabis advertising and its association with cannabis use and intentions.

Keine Richtungsangabe GRADE Moderat
Stichprobek = 21 Studien
n = 18 Pat.
DesignMeta-Analyse
Zusammenfassung

Systematische Review + Meta-Analyse zu Cannabis-Werbung und Cannabis-Konsum (k=21 Studien, davon 10 in Meta-Analyse poolbar). Cross-sektionale Meta-Analyse: Cannabis-Werbeexposition vs. kein Kontakt assoziiert mit Cannabis-Konsum (aOR=1.77, 95% CI [1.32, 2.30], p<0.05); General-Advertising-Subgruppe aOR=1.67 [1.27, 2.21]. Moderate Heterogenität I²=42.3% (Q=22.73, p<0.05). 18/21 Studien cross-sektional, 3 longitudinal; Setting USA/Kanada, Alter 11–65+ Jahre.

Vertrauen in die Evidenz
Moderat

Dritte von vier GRADE-Stufen, die Effektschätzung ist wahrscheinlich verlässlich.

Herabgestuft wegen
Ungenauigkeit
Qualitätsprofil
Größe
Verblindung
Effektstärke
Zitate / Jahr
Autoren
McClure-Thomas C, Yimer T, Strong C, Sun T, Hall WD, Chan GCK, Connor JP, Leung J
DOI 10.1111/add.70310
Design: Meta-Analyse
Teilen
Abstract
Background And Aims: Global changes in cannabis legislation have raised concerns about the potential impact of cannabis advertising on cannabis use and intentions to use. This systematic review and meta-analysis evaluated the relationship between self-reported exposure to cannabis advertising across various media platforms and self-reported cannabis use and use intentions. Design: Systematic review and meta-analysis of eligible quantitative studies using random-effects models. Setting: All included studies were conducted in the United States or Canada. Participants: Participants ranged in age from 11 to 65 + years across 21 included studies. Measurements: Studies measured self-reported exposure to cannabis-related advertising and either cannabis use or intentions to use cannabis. Three types of exposure were examined: [1] general cannabis advertising (a composite measure including billboards, storefront/sidewalk, magazines, social media, and other types of advertising avenues), [2] internet/social media advertising, and [3] storefront/sidewalk advertising. Findings: A total of 2588 records were identified through database searches (PubMed, Scopus, and PsycINFO; January 2024). After title and abstract screening, 45 underwent full text review; of these, 21 studies met inclusion criteria. Most were cross-sectional (86%, n = 18), and three were longitudinal. Ten cross-sectional studies were eligible for meta-analysis, which found a statistically significant association between cannabis advertising exposure and cannabis use (adjusted odds ratio [aOR] = 1.77, 95% confidence interval [CI] [1.32, 2.30]). Statistically significant heterogeneity was found (Q [11] = 22.73, P < 0.05, I(2) = 42.3%) and therefore, based on methodological comparability, three additional meta-analyses were conducted by exposure type. General cannabis advertising (3 studies) exposure was statistically significantly associated with cannabis use (aOR = 1.67, 95% CI [1.27, 2.21]); internet/social media advertising (5 studies) also showed a statistically significant association (aOR = 3.38, 95% CI [1.07, 10.66]); exposure to storefront/sidewalk advertising (3 studies) was not statistically significantly associated with cannabis use (aOR = 1.25, 95% CI [0.95, 1.66]). Across studies, methodological quality was mostly good (48%) or satisfactory (43%), with 10% rated as unsatisfactory. Conclusion: There appears to be a generally positive association between exposure to cannabis advertising and cannabis use, with a consistent positive relationship observed between advertising exposure and intentions to use.

„Was dem Handeln im Weg steht, wird zum Weg.“ — Marc Aurel